Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage

Journal of Pharmaceutical Sciences

Volumn 101, Issue 8, 2012, Pages 2909-2916

  Hama, Susumu ^a   Takahashi, Kanako ^a   Inai, Yuko ^a   Shiota, Kanako ^a   Sakamoto, Ryota ^a   Yamada, Asako ^a   Tsuchiya, Hiroyuki ^a   Kanamura, Kiyoshi ^b   Yamashita, Eiji ^c   Kogure, Kentaro ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b TTI Ellebeau Inc   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Astaxanthin; Iontophoresis; Liposomes; Oxidation; Reactive oxygen species; Skin; Transdermal drug delivery; UV

Indexed keywords

ANTIOXIDANT; ASTAXANTHIN; COLLAGEN TYPE 1; LIPOSOME; MELANIN; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; IMMUNOHISTOCHEMISTRY; IONTOPHORESIS; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; OXIDATION; RADIATION EXPOSURE; SKIN DISEASE; ULTRAVIOLET RADIATION;

EID: 84862864775     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23216     Document Type: Article

References (27)

1. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. 2003. UV-induced skin damage. Toxicology 189(1-2):21-39.
2. Svobodova A, Walterova D, Vostalova J. 2006. Ultraviolet light induced alteration to the skin. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150(1):25-38.
3. Kagan VE, Kisin ER, Kawai K, Serinkan BF, Osipov AN, Serbinova EA, Wolinsky I, Shvedova AA. 2002. Toward mechanism-based antioxidant interventions. Lessons from natural antioxidants. Ann N Y Acad Sci 959:188-198.
4. Svobodová A, Psotová J, Walterová D. 2003. Natural phenolics in the prevention of UV-induced skin damage. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147(2):137-145.
5. Boussiba S, Fan L, Vonshak A. 1992. Enhancement and determination of astaxanthin accumulation in green alga Haematococcus pluvialis. Method Enzymol 213:386-391.
6. Maoka T. 2011. Carotenoids in marine animals. Mar Drugs 9(2):278-293.
7. Terao J. 1989. Antioxidant activity of beta-carotene-related carotenoids in solution. Lipids 24(7):659-661.
8. Lim BP, Nagao A, Terao J, Tanaka K, Suzuki T, Takama K. 1992. Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. Biochim Biophys Acta 1126(2):178-184.
9. Palozza P, Krinsky NI. 1992. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch Biochem Biophys 297(2):291-295.
10. Goto S, Kogure K, Abe K, Kimata Y, Kitahama K, Yamashita E, Terada H. 2001. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta 1512(2):251-258.
11. Stahl W, Sies H. 2005. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta 1740(2):101-107.
12. Camera E, Mastrofrancesco A, Fabbri C, Daubrawa F, Picardo M, Sies H, Stahl W. 2009. Astaxanthin, canthaxanthin and b-carotene differently affect UVA-induced oxidative damage and expression of oxidative stress-responsive enzymes. Exp Dermatol 18(3):222-231.
13. Suganuma K, Nakajima H, Ohtsuki M, Imokawa G. 2010. Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1 and skin fibroblast elastase in human dermal fibroblasts. J Dermatol Sci 58(2):136-142.
14. O'Sullivan SM, Woods JA, O'Brien NM. 2004. Use of Tween 40 and Tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers. Br J Nutr 91(5):757-764.
15. Lockwood SF, O'Malley S, Mosher GL. 2003. Improved aqueous solubility of crystalline astaxanthin (3, 3′-dihydroxy-beta, beta-carotene-4, 4′-dione) by Captisol (sulfobutyl ether beta-cyclodextrin). J Pharm Sci 92(4):922-926.
16. Kajimoto K, Yamamoto M, Watanabe M, Kigasawa K, Kanamura K, Harashima H, Kogure K. 2011. Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis. Int J Pharm 403(1-2):57-65.
17. Fukuzawa K, Inokami Y, Tokumura A, Terao J, Suzuki A. 1998. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes. Lipids 33(8):751-756.
18. Hosaka S, Obuki M, Nakajima J, Suzuki M. 2005. Comparative study of antioxidants as quenchers or scavengers of reactive oxygen species based on quenching of MCLA-dependent chemiluminescence. Luminescence 20(6):419-427.
19. Shimoda H, Tanaka J, Shan SJ, Maoka T. 2010. Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules. J Pharm Pharmacol 62(9):1137-1145.
20. Scharffetter-Kochanek K, Wlaschek M, Briviba K, Sies H. 1993. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett 331(3):304-306.
21. Fisher GJ, Datta S, Wang ZQ, Li XY, Quan T, Chung JH, Kang S, Voorhees JJ. 2000. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 106:663-670.
22. Tanaka H, Yamaba H, Kosugi N, Mizutani H, Nakata S. 2008. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression. Arch Dermatol Res 300(Suppl 1):S57-S64.
23. Kawaguchi Y, Tanaka H, Okada T, Konishi H, Takahashi M, Ito M, Asai J. 1996. The effects of ultraviolet A and reactive oxygen species on the mRNA expression of 72-kDa type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts. Arch Dermatol Res 288(1):39-44.
24. Bikádi Z, Hazai E, Zsila F, Lockwood SF. 2006. Molecular modeling of non-covalent binding of homochiral (3S, 3′S)-astaxanthin to matrix metalloproteinase-13 (MMP-13). Bioorg Med Chem 14(16):5451-5458.
25. Kigasawa K, Kajimoto K, Hama S, Saito A, Kanamura K, Kogure K. 2010. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Int J Pharm 383(1-2):157-160.
26. Kigasawa K, Kajimoto K, Nakamura T, Hama S, Kanamura K, Harashima H, Kogure K. 2011. Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy. J Control Release 150(3):256-265.
27. Prausnitz MR, Langer R. 2008. Current status and future potential of transdermal drug delivery. Nat Biotechnol 26(11):1261-1268.